ArticleFrontiers in medicine2025
Fatigue as main symptom in an elderly multiple myeloma patient: a Case Report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Current Role of Physiotherapy in Systemic Light-Chain (AL) Amyloidosis and Multiple Myeloma.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The high prevalence of fatigue as an atypical clinical manifestation in general practice creates notable diagnostic challenges, particularly in geriatric patients. Methods: We describe a case of an 80-year-old female presenting with fatigue, initially attributed to poorly controlled diabetes mellitus or upper respiratory infection, who was ultimately diagnosed with multiple myeloma after admitted to the Department of General Medicine at a general hospital. Initial diagnostic workup including physical examination revealed the presence of anterior thoracic mass with undetermined etiology. Laboratory analysis demonstrated characteristic hematological abnormalities: normocytic anemia (hemoglobin 91 g/L), significant hyperglobulinemia (serum globulin 76.18 g/L), and hypoalbuminemia (serum albumin 27.94 g/L), showing a reversed albumin-globulin (A/G) ratio of 0.37. Guided by Murtagh's safe diagnostic strategy, comprehensive imaging studies including contrast-enhanced cervical, thoracoabdominal computed tomography (CT) and 18F-FDG PET-CT were performed. Histopathological confirmation was obtained from the gastric mass (CD138 Results: The patient was transferred to Hematology Department for further therapy. Clinical reassessment at 6-week follow-up showed symptomatic improvement and anterior thoracic mass regression. Discussion: We report a diagnostic case study of a MM patient whose initial presentation was fatigue, and clinicians should prioritize the overall condition, reduce diagnostic delays and improve therapeutic outcomes through early intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.